Alcon AG vs Synchrony Financial — how do they compare? Alcon AG trades at $72.57 (market cap $36.44B), while Synchrony Financial trades at $78.6 (market cap $25.53B). The key difference: Alcon AG is the larger of the two by market cap, and Synchrony Financial pays the higher dividend (1.73%). Which is the better fit depends on your goals.
| ALC | SYF | |
|---|---|---|
Market Cap | $36.44B | $25.53B |
Sector | Health | Financials |
52-Week High | $90.12 | $88.47 |
52-Week Low | $62.02 | $63.78 |
Enterprise Value | $40.28B | — |
Dividend Yield | 0.48% | 1.73% |
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →